Replies to post #251510 on Biotech Values

[zipjet]

Skip Virgin is impressive.

Education and Early Career
Herbert "Skip" Virgin, also known as Herbert W. Virgin IV, has a distinguished academic background. He completed his undergraduate studies at Harvard University, where he received his AB degree. He continued his education at Harvard Medical School, earning both an MD and a PhD. His thesis work focused on host immune responses to Listeria monocytogenes


Medical and Postdoctoral Training
After his doctoral studies, Virgin completed his residency in internal medicine at Brigham and Women's Hospital. He then underwent postdoctoral training in viral genetics and pathogenesis in the laboratory of Bernard Fields


Academic Positions
Virgin served as the Edward Mallinckrodt Professor and Chair of the Department of Pathology and Immunology at the Washington University School of Medicine (WUSM) in Saint Louis, USA. He held this position until 2018 and was succeeded by Richard J. Cote


Research Contributions
Throughout his career, Virgin's research has been influential in the fields of virology and immunology. His laboratory used genetic, structural, computational, and sequencing methods to explore the relationship between host genes, the virome, and disease pathogenesis. Notably, his team discovered the first murine norovirus and developed the first culture and genetic systems for a norovirus. They also identified the role of bacteria in norovirus persistence and linked changes in the enteric virome with human inflammatory bowel disease



Virgin's work has also contributed to understanding the roles of autophagy and interferon-stimulated genes during viral infection. His research has implications for a range of conditions, including chronic viral infection, lung inflammation, and autoimmune diseases


Industry Experience
In the industrial sector, Virgin served as Chief Scientific Officer at Vir Biotechnology from 2018-2022. During his tenure, he directed the discovery of the monoclonal antibody sotrovimab for the treatment of COVID-19 in at-risk individuals


Altos Labs Involvement
Most recently, Virgin was appointed as Chief Medical Officer and Head of the Altos Institute of Medicine at Altos Labs, where he was responsible for leading work on the translatability of scientific discoveries to transformative medicines. However, as of December 2023, he is no longer serving in this role



Honors and Memberships
Virgin is a member of several prestigious societies, including the National Academy of Sciences (NAS), the American Society for Clinical Investigation (ASCI), the American Association of Physicians (AAP), the American Academy of Microbiology (AAM), and the American Association for the Advancement of Science (AAAS). He also serves on the editorial boards of prominent journals such as Cell and Science


Publications
Virgin has authored numerous influential publications, some of which include studies on herpesvirus latency, interferon responses to murine norovirus, and the discovery of a proteinaceous cellular receptor for a norovirus


Contact Information
While specific contact details are not provided in the search results, professional profiles such as LinkedIn and institutional affiliations can be used to establish contact with Dr. Virgin


Summary
Herbert "Skip" Virgin's CV reflects a career dedicated to advancing the understanding of virology and immunology through both academic and industry roles. His contributions to the field have been recognized by his peers and have had a significant impact on medical research and treatment development.